STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session SHMD SCHMID cites robust semiconductor and clean energy equipment pipelines to support nearterm growth What independent research Investar ISTR Market Focus 20260427 Target Corporation TGT Guggenheim Price Target Upgrade Confirms Accelerating Turnaround Momentum EVG Eaton outlines portfolio adjustment plans for its short duration income fund to lift future quarterly performance